Regulatory GSK claims FDA okay for first oral carbapenem antibiotic PharmaphorumGSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.Infectious DiseaseRead full story pharminent June 18, 2026 (Last updated: June 19, 2026) Pharmaphorum GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi. Infectious Disease Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: LG AI Research and D&D Pharmatech sign agreement for oral peptide drugsNext: Cardio biotech Kardigan binds off $400M upsized IPO Related Stories Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026 Regulatory Outlook finally claims FDA approval for AMD drug pharminent July 27, 2026 Regulatory Outlook Therapeutics wins FDA approval for Lytenava in wet AMD pharminent July 27, 2026
